The diagnosis and staging of lung cancer is an important process that identifies treatment options and guides disease prognosis. Therefore, an accurate mediastinal lymph node staging is required not only to offer the appropriate treatment but also to avoid unnecessary invasive procedures. Currently, EBUS-TBNA is the preferred modality for sampling mediastinal lymph nodes because of its minimally invasive nature and high diagnostic yield. In this review, we discuss the utility of EBUS in mediastinal lymph node staging of of non-small cell lung cancer (NSCLC).
Relevance for patients: The use of EBUS-TBNA in the diagnosis of mediastinal and hilar lymph node pathology has become in an essential endoscopic technique and the first step for staging of lung cancer.
1. Respiratory Medicine. Hospital de la Santa Creu i Sant Pau. Barcelona.
2. Biomedical Research Institute Sant Pau (IIB-Sant Pau). Barcelona.
3. Thoracic Surgery Department. Hospital de la Santa Creu i Sant Pau. Barcelona.
Virginia Pajares Ruiz,
Respiratory Medicine. Hospital de la Santa Creu i Sant Pau C/ Sant Antoni Mª Claret, 167. CP: 08025. Barcelona (Spain)
Oncologic Group for the Study of Lung Cancer, Spanish Radiation Oncology Society
Radiation Oncology Department, Hospital Universitario Quirónsalud Madrid; Hospital La Luz, Madrid; Universidad Europea de Madrid, Spain